DividendInvestor.com
First In Dividend Data Worldwide®
DIVIDEND ANNOUNCEMENT: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ:CNCR) on 12/29/2020 declared a dividend of $0.2881 per share
Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ:CNCR) on 12/29/2020 declared a dividend of $ 0.2881 per share payable on January 04, 2021 to shareholders of record as of December 31, 2020. Dividend amount recorded is a decrease of $ 0.0621 from last dividend Paid.
Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ:CNCR) has paid dividends since 2016, has a current dividend yield of 0.8852258921% and has increased its dividends for 0 successive years.
Loncar Cancer Immunotherapy ETF/ETF Series Solutions's market cap is $ 3,276,000 and has a PE ratio of 0.00. The stock price closed yesterday at $ 32.76 and has a 52 week low/high of $ 12.00 and $ 34.37.
For more information on Loncar Cancer Immunotherapy ETF/ETF Series Solutions click here.
Dividend Ex Date: December 30, 2020
Dividend Record Date: December 31, 2020
Dividend Payment Date: January 04, 2021
Dividend Amount: $ 0.2881
CNCR LINKS
CNCR Dividend History Detail
CNCR Projected 10 Year Dividend Yield
CNCR Dividend News
CNCR Competitors News
DividendInvestor.com
DividendInvestor.com is a leading worldwide independent provider of dividend information and data for investment professionals. Our mission is to be the First In Dividend Data Worldwide® by designing and developing essential tools and systems for the investment community with the highest level of accuracy and integrity.
Contact:
info@DividendInvestor.com